While complying with local directives, Cellecta is fully operational. Normal turnaround times have not been affected by COVID-19 more >
Catalog #: SGCTL-NT-pRSG17
$300.00
Non-targeting sgRNA in a standard lentiviral construct. Used as a negative control for CRISPR.